Targeted Protein Degradation Provides Promising Alternative to Address Unmet Medical Needs

NEOsphere Biotechnologies' Henrik Daub, Ph.D., discusses how new technological advances in proteomics and mass spectrometry are facilitating the discovery of novel targets for targeted protein degradation therapeutic approaches.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: